At the end of the day, the protection and promotion of the safety of Canadian patients is the top priority, for us as well as for Health Canada. And as long as that takes precedence over all other priorities, no dual mandate exists.
Vice-President, Government Affairs, Canada's Research-Based Pharmaceutical Companies (Rx & D)
At the end of the day, the protection and promotion of the safety of Canadian patients is the top priority, for us as well as for Health Canada. And as long as that takes precedence over all other priorities, no dual mandate exists.
See context to find out what was said next.